1-9 of 9
Jaime A. Davidson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comment on Riddle et al. Diabetes Care Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes Care 2019;42:1136–1146

Laura Lee Hall, Gary A. Puckrein, Jaime A. Davidson
Journal: Diabetes Care
Diabetes Care 2019;42(11):e183
https://doi.org/10.2337/dc19-1262
Published: 10 October 2019
View article titled, Comment on Riddle et al. <em>Diabetes Care</em> Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes Care 2019;42:1136–1146
Open the PDF for Comment on Riddle et al. <em>Diabetes Care</em> Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes Care 2019;42:1136–1146 in another window
Journal Articles

Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis

Gary A. Puckrein, Gail Nunlee-Bland, Farhad Zangeneh, Jaime A. Davidson, Robert A. Vigersky, Liou Xu, Christopher G. Parkin, David G. Marrero
Journal: Diabetes Care
Diabetes Care 2016;39(4):563–571
https://doi.org/10.2337/dc15-1264
Published: 15 March 2016
View article titled, Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis
Open the PDF for Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis in another window
Journal Articles

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Jacob A. Udell, Deepak L. Bhatt, Eugene Braunwald, Matthew A. Cavender, Ofri Mosenzon, Ph. Gabriel Steg, Jaime A. Davidson, Jose C. Nicolau, Ramon Corbalan, Boaz Hirshberg, Robert Frederich, KyungAh Im, Amarachi A. Umez-Eronini, Ping He, Darren K. McGuire, Lawrence A. Leiter, Itamar Raz, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2015;38(4):696–705
https://doi.org/10.2337/dc14-1850
Published: 31 December 2014
View article titled, Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
Open the PDF for Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes

Jaime A. Davidson, MD, FACE, Christopher G. Parkin, MS
Journal: Diabetes Care
Diabetes Care 2009;32(suppl_2):S331–S333
https://doi.org/10.2337/dc09-S333
Published: 01 November 2009
View article titled, Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: <subtitle>Does proving this relationship really matter? Yes</subtitle>
Open the PDF for Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: <subtitle>Does proving this relationship really matter? Yes</subtitle> in another window
Journal Articles

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes : Response to Nathan et al.

Paul S. Jellinger, MD, MACE, Harold E. Lebovitz, MD, FACE, Jaime A. Davidson, MD, FACE, on behalf of the ACE/AACE Outpatient Glycemic Control Implementation Task Force
Journal: Diabetes Care
Diabetes Care 2007;30(4):e16–e17
https://doi.org/10.2337/dc06-2373
Published: 01 April 2007
View article titled, Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes : <subtitle>Response to Nathan et al.</subtitle>
Open the PDF for Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes : <subtitle>Response to Nathan et al.</subtitle> in another window
Journal Articles

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Nathan et al.

Christopher G. Parkin, MS, Jaime A. Davidson, MD, FACP, FACE
Journal: Diabetes Care
Diabetes Care 2007;30(1):192–193
https://doi.org/10.2337/dc06-1858
Published: 01 January 2007
View article titled, Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: <subtitle>Response to Nathan et al.</subtitle>
Open the PDF for Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: <subtitle>Response to Nathan et al.</subtitle> in another window
Journal Articles

New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: An endocrinologist’s view

Jaime A Davidson, MD, Alan Wilkinson, MD, on behalf of the International Expert Panel on New-Onset Diabetes after Transplantation
Journal: Diabetes Care
Diabetes Care 2004;27(3):805–812
https://doi.org/10.2337/diacare.27.3.805
Published: 01 March 2004
View article titled, New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: <subtitle>An endocrinologist’s view</subtitle>
Open the PDF for New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: <subtitle>An endocrinologist’s view</subtitle> in another window
Journal Articles

Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients

Peter S Johnston, MD, Peter U Feig, MD, Robert F Coniff, MD, Alice Krol, MS, Jaime A Davidson, MD, Steven M Haffner, MD
Journal: Diabetes Care
Diabetes Care 1998;21(3):409–415
https://doi.org/10.2337/diacare.21.3.409
Published: 01 March 1998
View article titled, Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
Open the PDF for Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients in another window
Journal Articles

The Treatment of Type II Diabetes in Texas: Current issues for managed care and employers

Jaime A Davidson, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):446–451
https://doi.org/10.2337/diacare.20.3.446
Published: 01 March 1997
View article titled, The Treatment of Type II Diabetes in Texas: Current issues for managed care and employers
Open the PDF for The Treatment of Type II Diabetes in Texas: Current issues for managed care and employers in another window